Zdrowie i gospodarka · 22/07/2005

FDA Releases Guidance for Estimating Safe Starting Dose in Clinical Trials

The Food and Drug Administration (FDA) has published a guidance document to help pharmaceutical companies determine the maximum safe starting dose for new treatments in healthy adult volunteers during initial clinical trials.